Therapeutic Effects of Zoledronic Acid-Loaded Hyaluronic Acid/Polyethylene Glycol/Nano-Hydroxyapatite Nanoparticles on Osteosarcoma

Zoledronic acid (ZOL) has been approved as the only bisphosphonate for the prevention and treatment of metastatic bone diseases with acceptable safety and tolerability. However, systemic or direct injection of ZOL often causes severe side effects, which limits its clinical application. Here, an inno...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yan, Qi, Jingqi, Sun, Wei, Zhong, Wu, Wu, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181619/
https://www.ncbi.nlm.nih.gov/pubmed/35694235
http://dx.doi.org/10.3389/fbioe.2022.897641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181619/
https://www.ncbi.nlm.nih.gov/pubmed/35694235
http://dx.doi.org/10.3389/fbioe.2022.897641

Ejemplares similares